Literature DB >> 8914196

Characterization, formulation, and stability of Neupogen (Filgrastim), a recombinant human granulocyte-colony stimulating factor.

A C Herman1, T C Boone, H S Lu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914196     DOI: 10.1007/0-306-47452-2_7

Source DB:  PubMed          Journal:  Pharm Biotechnol        ISSN: 1078-0467


× No keyword cloud information.
  19 in total

1.  The influence of polysorbate 80 on the radiochemical synthesis of a PET tracer in the FASTlab.

Authors:  Wai Lam Yip; Sverre Arne Sande; David Grace; Dirk Jan in't Veld; Per Christian Sontum; Tina Solvang; Knut Dyrstad
Journal:  Pharm Res       Date:  2014-10-31       Impact factor: 4.200

2.  Monitoring Effects of Excipients, Formulation Parameters and Mutations on the High Order Structure of Filgrastim by NMR.

Authors:  Yves Aubin; Derek J Hodgson; William B Thach; Geneviève Gingras; Simon Sauvé
Journal:  Pharm Res       Date:  2015-06-05       Impact factor: 4.200

3.  Mass spectrometric distinction of in-source and in-solution pyroglutamate and succinimide in proteins: a case study on rhG-CSF.

Authors:  Mukesh Kumar; Amarnath Chatterjee; Anand P Khedkar; Mutyalasetty Kusumanchi; Laxmi Adhikary
Journal:  J Am Soc Mass Spectrom       Date:  2013-01-03       Impact factor: 3.109

4.  Expression and one step intein-mediated purification of biologically active human G-CSF in Escherichia coli.

Authors:  Setareh Sima; Fatemeh Shafiee; Ali Jahanian-Najafabadi
Journal:  Mol Biol Rep       Date:  2020-03-29       Impact factor: 2.316

5.  Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state.

Authors:  Stephen W Raso; Jeff Abel; Jesse M Barnes; Kevin M Maloney; Gary Pipes; Michael J Treuheit; Jonathan King; David N Brems
Journal:  Protein Sci       Date:  2005-09       Impact factor: 6.725

6.  Effects of excipients on the hydrogen peroxide-induced oxidation of methionine residues in granulocyte colony-stimulating factor.

Authors:  Jin Yin; Jhih-Wei Chu; Margaret Speed Ricci; David N Brems; Daniel I C Wang; Bernhardt L Trout
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

7.  Determination of Critical Quality Attributes for a Biotherapeutic in the QbD Paradigm: GCSF as a Case Study.

Authors:  Sumit K Singh; Deepak Kumar; Anurag S Rathore
Journal:  AAPS J       Date:  2017-09-05       Impact factor: 4.009

8.  Mechanism of Decarboxylation of Pyruvic Acid in the Presence of Hydrogen Peroxide.

Authors:  Antonio Lopalco; Gautam Dalwadi; Sida Niu; Richard L Schowen; Justin Douglas; Valentino J Stella
Journal:  J Pharm Sci       Date:  2016-01-29       Impact factor: 3.534

9.  An engineered 4-1BBL fusion protein with "activity on demand".

Authors:  Jacqueline Mock; Marco Stringhini; Alessandra Villa; Michael Weller; Tobias Weiss; Dario Neri
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-25       Impact factor: 11.205

10.  Anion binding mediated precipitation of a peptibody.

Authors:  Atul Saluja; Shon Crampton; Eva Kras; R Matthew Fesinmeyer; Richard L Remmele; Linda O Narhi; David N Brems; Yatin R Gokarn
Journal:  Pharm Res       Date:  2008-09-27       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.